Detalhe da pesquisa
1.
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 403(10423): 249-260, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048786
2.
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Am J Hematol
; 99(4): 763-766, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317312
3.
Treatment strategies for myelodysplastic syndrome in 2021.
Vnitr Lek
; 67(3): 150-155, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171954
4.
Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone.
Acta Medica (Hradec Kralove)
; 59(2): 50-3, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27526305
5.
[Impact of age on the clinical response of patients with CML treated with imatinib]. / Má vek nemocných s chronickou myeloidní leukemií pri lécbe imatinibem vliv na dosazenou lécebnou odpoved?
Vnitr Lek
; 61(9): 785-6, 788-91, 2015 Sep.
Artigo
em Cs
| MEDLINE | ID: mdl-26465277
6.
[Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience]. / První ceské zkusenosti s lenalidomidem v terapii anemických nemocných s myelodysplastickým syndromem s delecí dlouhého ramene 5. chromozomu.
Vnitr Lek
; 61(12): 1028-33, 2015 Dec.
Artigo
em Cs
| MEDLINE | ID: mdl-26806497
7.
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.
Hematol Oncol
; 32(2): 87-93, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23963760
8.
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
Leukemia
; 38(2): 318-325, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129513
9.
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Am J Hematol
; 93(10): E342-E345, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054949
10.
MonoMAC syndrome with GATA2 novel mutation: A case report.
Leuk Res Rep
; 18: 100346, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119727
11.
New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Acta Haematol
; 125(4): 193-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21252495
12.
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice.
Leuk Lymphoma
; 62(1): 194-202, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021423
13.
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter.
Leuk Res
; 81: 67-74, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31051328
14.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Leukemia
; 38(4): 893-897, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472478
15.
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
Arch Med Sci
; 14(6): 1416-1423, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393497
16.
Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis.
Acta Medica (Hradec Kralove)
; 55(3): 142-5, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297524
17.
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
J Exp Clin Cancer Res
; 36(1): 55, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420426
18.
Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study.
Leuk Lymphoma
; 61(2): 494-496, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580157
19.
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes.
Leuk Res
; 37(12): 1612-5, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23937987
20.
Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and intermediate-1).
Leuk Res
; 36(12): e222-4, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22954608